HomeRANI β’ NASDAQ
Rani Therapeutics Holdings Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 172.00K | β |
Operating expense | 12.19M | -13.18% |
Net income | -7.26M | 2.93% |
Net profit margin | -4.22K | β |
Earnings per share | -0.22 | 24.14% |
EBITDA | -11.76M | 14.68% |
Effective tax rate | β | β |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.85M | -59.95% |
Total assets | 24.13M | -54.92% |
Total liabilities | 29.47M | -24.38% |
Total equity | -5.35M | β |
Shares outstanding | 33.57M | β |
Price to book | -5.64 | β |
Return on assets | -98.86% | β |
Return on capital | -112.22% | β |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.26M | 2.93% |
Cash from operations | -8.15M | 13.33% |
Cash from investing | 18.23M | 77.08% |
Cash from financing | -3.73M | -3,183.47% |
Net change in cash | 6.35M | 526.75% |
Free cash flow | -3.37M | 9.75% |
Previous close
$0.51
Day range
$0.50 - $0.52
Year range
$0.46 - $4.37
Market cap
28.79M USD
Avg Volume
707.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
106
